Cargando…

Growth kinetics of multiple Acinetobacter baumannii resistotype after meropenem-based antibiotic combination exposure

Background: Carbapenems are the treatment of choice for multidrug-resistant (MDR) and extensively drug-resistant (XDR)  Acinetobacter baumannii infections, but the emergence of carbapenem-resistant  A. baumannii (CRAB) has rendered it ineffective in the vast majority of cases. Combination therapy ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Rivani, Erizka, Endraswari, Pepy Dwi, Widodo, Agung Dwi Wahyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723411/
https://www.ncbi.nlm.nih.gov/pubmed/36531260
http://dx.doi.org/10.12688/f1000research.122221.2
_version_ 1784844169760473088
author Rivani, Erizka
Endraswari, Pepy Dwi
Widodo, Agung Dwi Wahyu
author_facet Rivani, Erizka
Endraswari, Pepy Dwi
Widodo, Agung Dwi Wahyu
author_sort Rivani, Erizka
collection PubMed
description Background: Carbapenems are the treatment of choice for multidrug-resistant (MDR) and extensively drug-resistant (XDR)  Acinetobacter baumannii infections, but the emergence of carbapenem-resistant  A. baumannii (CRAB) has rendered it ineffective in the vast majority of cases. Combination therapy has grown in popularity over the last decade; this study aims to analyze  A.baumannii growth kinetics after exposure to meropenem and ampicillin-sulbactam compared with meropenem and amikacin antibiotic combinations in clinically relevant concentrations.  Methods: This experimental laboratory study was conducted on the  A. baumannii ATCC 19606 isolate and three clinical isolates that were intermediate or resistant to tested antibiotics. Meropenem and ampicillin-sulbactam, as well as meropenem and amikacin, were tested at four different concentrations against isolates. Turbidity measurements were taken at predetermined time points of 0, 1, 2, 4, 6, 8, and 24 hours following exposure; bacterial concentration was enumerated using the agar plate method, with the results plotted in a time-kill curve.   Results: A bactericidal effect was achieved in isolates that were intermediate to ampicillin-sulbactam and resistant to meropenem after the administration of meropenem and ampicillin-sulbactam combination with a concentration of 4 µg/ml and 16/8 µg/ml, respectively. The combination of meropenem and ampicillin-sulbactam demonstrated bacteriostatic activity against isolates that were resistant to both antibiotics. Isolates treated with resistant antibiotics showed an increased growth rate compared to the growth control.  Conclusion: The combination of meropenem and ampicillin-sulbactam could be a promising combination therapy in treating CRAB infections. The mechanism and degree of antibiotic resistance in the isolates affect the efficacy of antibiotic combinations; further research is needed to corroborate the findings of this study.
format Online
Article
Text
id pubmed-9723411
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-97234112022-12-15 Growth kinetics of multiple Acinetobacter baumannii resistotype after meropenem-based antibiotic combination exposure Rivani, Erizka Endraswari, Pepy Dwi Widodo, Agung Dwi Wahyu F1000Res Brief Report Background: Carbapenems are the treatment of choice for multidrug-resistant (MDR) and extensively drug-resistant (XDR)  Acinetobacter baumannii infections, but the emergence of carbapenem-resistant  A. baumannii (CRAB) has rendered it ineffective in the vast majority of cases. Combination therapy has grown in popularity over the last decade; this study aims to analyze  A.baumannii growth kinetics after exposure to meropenem and ampicillin-sulbactam compared with meropenem and amikacin antibiotic combinations in clinically relevant concentrations.  Methods: This experimental laboratory study was conducted on the  A. baumannii ATCC 19606 isolate and three clinical isolates that were intermediate or resistant to tested antibiotics. Meropenem and ampicillin-sulbactam, as well as meropenem and amikacin, were tested at four different concentrations against isolates. Turbidity measurements were taken at predetermined time points of 0, 1, 2, 4, 6, 8, and 24 hours following exposure; bacterial concentration was enumerated using the agar plate method, with the results plotted in a time-kill curve.   Results: A bactericidal effect was achieved in isolates that were intermediate to ampicillin-sulbactam and resistant to meropenem after the administration of meropenem and ampicillin-sulbactam combination with a concentration of 4 µg/ml and 16/8 µg/ml, respectively. The combination of meropenem and ampicillin-sulbactam demonstrated bacteriostatic activity against isolates that were resistant to both antibiotics. Isolates treated with resistant antibiotics showed an increased growth rate compared to the growth control.  Conclusion: The combination of meropenem and ampicillin-sulbactam could be a promising combination therapy in treating CRAB infections. The mechanism and degree of antibiotic resistance in the isolates affect the efficacy of antibiotic combinations; further research is needed to corroborate the findings of this study. F1000 Research Limited 2022-11-28 /pmc/articles/PMC9723411/ /pubmed/36531260 http://dx.doi.org/10.12688/f1000research.122221.2 Text en Copyright: © 2022 Rivani E et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Brief Report
Rivani, Erizka
Endraswari, Pepy Dwi
Widodo, Agung Dwi Wahyu
Growth kinetics of multiple Acinetobacter baumannii resistotype after meropenem-based antibiotic combination exposure
title Growth kinetics of multiple Acinetobacter baumannii resistotype after meropenem-based antibiotic combination exposure
title_full Growth kinetics of multiple Acinetobacter baumannii resistotype after meropenem-based antibiotic combination exposure
title_fullStr Growth kinetics of multiple Acinetobacter baumannii resistotype after meropenem-based antibiotic combination exposure
title_full_unstemmed Growth kinetics of multiple Acinetobacter baumannii resistotype after meropenem-based antibiotic combination exposure
title_short Growth kinetics of multiple Acinetobacter baumannii resistotype after meropenem-based antibiotic combination exposure
title_sort growth kinetics of multiple acinetobacter baumannii resistotype after meropenem-based antibiotic combination exposure
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723411/
https://www.ncbi.nlm.nih.gov/pubmed/36531260
http://dx.doi.org/10.12688/f1000research.122221.2
work_keys_str_mv AT rivanierizka growthkineticsofmultipleacinetobacterbaumanniiresistotypeaftermeropenembasedantibioticcombinationexposure
AT endraswaripepydwi growthkineticsofmultipleacinetobacterbaumanniiresistotypeaftermeropenembasedantibioticcombinationexposure
AT widodoagungdwiwahyu growthkineticsofmultipleacinetobacterbaumanniiresistotypeaftermeropenembasedantibioticcombinationexposure